Tag archive for ‘Dr. Reddy’s Laboratories’
By businessnewstoday On Monday, February 22nd, 2021
0 Comments

Dr. Reddy’s seeks EUA for Russian Covid-19 vaccine Sputnik V from DCGI

(adsbygoogle = window.adsbygoogle || []).push({}); Dr. Reddy’s Laboratories said that it has started the process to seek the emergency use authorization (EUA) for the Russian Covid-19 vaccine Sputnik More...

By businessnewstoday On Thursday, February 18th, 2021
0 Comments

Dr. Reddy’s Laboratories launches Fluphenazine Hydrochloride Tablets in US

Dr. Reddy’s Laboratories, an Indian pharma company, has launched Fluphenazine Hydrochloride Tablets, USP, in the US market. Fluphenazine Hydrochloride Tablets, USP is a therapeutic equivalent generic version of More...

By pharmanewsdaily On Saturday, January 16th, 2021
0 Comments

Dr. Reddy’s Laboratories gets DCGI nod for phase 3 trial of Sputnik V vaccine

Dr. Reddy’s Laboratories has secured the go-ahead from the Drugs Control General of India (DCGI) to begin phase 3 clinical trial for the Russian Covid-19 vaccine Sputnik V in India. The Indian pharma company plans More...

By pharmanewsdaily On Thursday, January 14th, 2021
0 Comments

Dr. Reddy’s reports success for Russian Covid-19 vaccine Sputnik V

Indian pharma company Dr. Reddy’s Laboratories announced that Sputnik V, a registered Covid-19 vaccine in Russia, has succeeded in a phase 2 trial in India by meeting the primary endpoint of safety. An independent More...